UDP-
N-acetylglucosamine: alpha-6-D-mannoside beta-1,6N-acetylglucosaminyltransferase-V activities were determined in human
hepatoma cell lines of Hep3B and HepG2, and also compared with those of normal liver tissues and primary hepatocytes. When GlcNAcbeta1-2Manalpha1-3(GlcNAcbeta1-2Manalpha1-4)(Manbeta1-4GlcNAc-2-amino
pyridine (GlcN,GlcN-biant-PA) and
UDP-GlcNAc were used as substrates, the
enzymes displayed optimum temperatures of 50 degrees C, optimum pHs of 6.5 in each case, K(m) values for
UDP-GlcNAc to be 5.8 (Hep3B) and 4.5 mM (HepG2) and K(m) values for GlcN,GlcN-biant-PA (mM) to be 1.28 (Hep3B) and 2.4 (HepG2). This indicates that values of Hep3B
GlcNAc-transferase-V were distinguishable with HepG2
enzyme. Furthermore, Hep3B
enzyme in membrane fraction showed about 1.5-fold higher specific activity (1.423 pmol/(h mg) than that (1.066 pmol/(h mg)) of HepG2. Normal hepatocytes are characterized by very low level of
GlcNAc-transferase-V activity whereas
hepatoma cells contained high activities. Treatment of
hepatoma cells with
retinoic acid and 1alpha,2,5-dihydroxyvitamin D(3) (Vit-D(3)) resulted in an increase in
GlcNAc-transferase-V activity, while treatment with
dimethyl sulfoxide and
cytosine-arabinoside resulted in decrease in the
enzyme activity. Although
retinoic acid (RA) treated cells shows a changed
GlcNAc-transferase-V
mRNA expression, expression of marker
proteins such as
alpha-fetoprotein and
albumin was not changed. This is the first demonstration of
GlcNAc-transferase-V activity in RA and Vit-D(3)-treated
hepatoma cell lines.